chenodeoxycholic acid has been researched along with Depressive Disorder, Major in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, H; Chen, P; Du, J; Feng, Y; Kan, W; Li, H; Li, L; Wang, G; Wang, W; Xu, J; Yang, J; Yang, Y; Zhu, X; Zou, Y | 1 |
1 other study(ies) available for chenodeoxycholic acid and Depressive Disorder, Major
| Article | Year |
|---|---|
The FXR mediated anti-depression effect of CDCA underpinned its therapeutic potentiation for MDD.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Depressive Disorder, Major; Gene Expression Regulation; Humans; Mice; Transcription Factors | 2023 |